Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Mol Immunol ; 10(2): 151-8, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23396474

ABSTRACT

The initial inflammatory phase of bone fracture healing represents a critical step for the outcome of the healing process. However, both the mechanisms initiating this inflammatory phase and the function of immune cells present at the fracture site are poorly understood. In order to study the early events within a fracture hematoma, we established an in vitro fracture hematoma model: we cultured hematomas forming during an osteotomy (artificial bone fracture) of the femur during total hip arthroplasty (THA) in vitro under bioenergetically controlled conditions. This model allowed us to monitor immune cell populations, cell survival and cytokine expression during the early phase following a fracture. Moreover, this model enabled us to change the bioenergetical conditions in order to mimic the in vivo situation, which is assumed to be characterized by hypoxia and restricted amounts of nutrients. Using this model, we found that immune cells adapt to hypoxia via the expression of angiogenic factors, chemoattractants and pro-inflammatory molecules. In addition, combined restriction of oxygen and nutrient supply enhanced the selective survival of lymphocytes in comparison with that of myeloid derived cells (i.e., neutrophils). Of note, non-restricted bioenergetical conditions did not show any similar effects regarding cytokine expression and/or different survival rates of immune cell subsets. In conclusion, we found that the bioenergetical conditions are among the crucial factors inducing the initial inflammatory phase of fracture healing and are thus a critical step for influencing survival and function of immune cells in the early fracture hematoma.


Subject(s)
Arthroplasty, Replacement, Hip/methods , Energy Metabolism/immunology , Fractures, Bone/immunology , Fractures, Bone/pathology , Hematoma/immunology , Hematoma/pathology , Aged , Cell Survival/immunology , Cells, Cultured , Chemokine CCL2/metabolism , Female , Femur/surgery , Fractures, Bone/metabolism , Hematoma/metabolism , Humans , Interferon-gamma/metabolism , Interleukin-6/metabolism , Interleukin-8/metabolism , Male , Middle Aged , Vascular Endothelial Growth Factor A/metabolism , Wound Healing/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...